Skip to content

Instrument-assisted Soft Tissue Mobilization Versus Integrated on Mechanical Neck Pain

Instrument-assisted Soft Tissue Mobilization Versus Integrated Neuromuscular Inhibition Technique on Mechanical Non-specific Neck Pain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04702100
Acronym
IASTM
Enrollment
90
Registered
2021-01-08
Start date
2021-01-01
Completion date
2021-03-30
Last updated
2022-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-specific Chronic Mechanical Neck Pain

Keywords

instrument-assisted soft tissue mobilization, integrated neuromuscular inhibition technique

Brief summary

the aim of this study is to investigate the efficacy of instrumented assisted soft tissue mobilization versus integrated neuromuscular inhibition technique on mechanical non-specific neck pain

Detailed description

Mechanical neck pain is a prevalent condition in various populations. Neck pain occurrence is affected by several factors, involving environmental, psychological, and social aspects. Neck pain represents the fourth major disorder responsible for a person's year lived with disability and ranked eleventh as disability-adjusted life years of a person. The neck pain incidence ranges from 10.4 to 23.3% in 1-year time, while the range of prevalence was 0.4 to 86.8%. It has a high prevalence among computer users, office workers, and females, especially females aged 35 to 49 years old. Myofascial trigger point (MTrP) might play an important role in the formation of mechanical neck pain and is known as a hyperirritable spot in skeletal muscle that is accompanied with a hypersensitive palpable nodule in a taut band. IASTM and integrated play an important role in the treatment of mechanical neck pain.this trial has three groups; one will receive IASTM+ conventional, the second will receive integrated + conventional and the third will receive conventional treatment for four week

Interventions

OTHERinstrument assisted soft tissue mobilization

the patients will receive instrument-assisted soft tissue mobilization:The subject was seated in a relaxed sitting position. M2T blade was used to find specific areas of restriction on RT upper trapezius. Then treatment plane 1 - 2 and 3 were used.The lubricant (Vaseline) was applied to the skin around the neck area prior to treatment and the tool was cleaned with an alcohol preparation pad. Then by using M2T blade with angle 45, we were giving long slow strokes without causing any discomfort or pain over muscle starting from its insertion up to its origin approximately for 2 to 3 min repeated two times.

OTHERintegrated neuromuscular inhibition technique

will receive integrated neuromuscular inhibition technique: from supine lying position.we the patients will perform ischemic compression at trigger points then positional release technique and finally muscle energy technique.

OTHERconventional therapy

the patients will receive hot back for 10 minutes, active range of motion exercise, chin tuck, stretches

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

random generator

Intervention model description

instrument assisted soft tissue mobilization and integrated neuromuscular inhibition technique

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
No

Inclusion criteria

1. diagnosed as non-specific neck pain with upper trapezius active myofascial trigger points less than 3 months of duration and have these criteria: taut band on palpation, hyper sensible tender spot in the taut band, local twitch response referred pain pattern 2. body mass index from 18 to 25 kg/m2 3. their ages from 18-35

Exclusion criteria

1. if they had trigger point injections within the past 6 months 2. history of neck or upper back surgery, trauma or fracture 3. history of a whiplash injury, skin diseases and lesions, any sensory disturbances, any vascular syndromes, neck and back deformities 4. cervical radiculopathy, and diagnosis of fibromyalgia syndrome, skin diseases

Design outcomes

Primary

MeasureTime frameDescription
pain intensityup to four weeksThe scale that will be used the VAS ;each subject will instructed to put point on line from no pain to tolerable pain

Secondary

MeasureTime frameDescription
neck disabilityup to four weekswill be measured by Arabic neck disability index
muscle amplitude in the form of normalized root mean square (RMS)up to four weeksmuscle amplitude will be measured by surface electromyography for upper trapezius
muscle fatigue in the form of median frequencyup to four weeksmuscle fatigue will be measured by surface electromyography for upper trapezius

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026